Chison Medical Technologies released its 2026 semi-annual report on the evening of August 27. In the first half of the year, the company achieved operating revenue of 241 million yuan, up 2.24 percent year on year, while net profit attributable to shareholders of the listed company was 68.96 million yuan, roughly flat compared with the same period last year. The company plans to distribute a cash dividend of 3.50 yuan per ten shares, before tax, to all shareholders, totaling 39.24 million yuan before tax, accounting for 56.91 percent of first-half net profit. On the product side, the company continued to refine its SonoFamily product matrix, officially launched the SonoGo series, strengthened AI computing power in the SonoPort series, and expanded horizontally into the veterinary ultrasound field. In research and development, the company's first-half R&D expenses accounted for 16.52 percent of operating revenue, and it held a total of 697 intellectual property rights, including 167 invention patents. In terms of globalization, the company has established sales networks in more than 100 countries and regions worldwide and deepened cooperation with international companies such as Canon, BD, and Philips.
Canon Inc.
Becton Dickinson and Company
Ability Enterprise Co Ltd
Koninklijke Philips NVChison Medical Technologies Co LtdCompany reports revenue growth and declares cash dividend, positive for shareholders.
